Study ID Number Study Title Institute Species Analysis
ST0002421 metabolitesWhole unconditioned medium (Defined culture media, M199),Whole M1 medium,Whole M2 mediumMayo ClinicHomo sapiensMS
ST0004031 metabolitesMetabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytesMonash UniversityHomo sapiensMS
ST0005391 metabolitesMetabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II)Monash UniversityHomo sapiensMS
ST0005461 metabolitesMulti-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant PlasmodiumMonash UniversityPlasmodium falciparumMS
ST0009741 metabolitesGC6-74 matabolomic of TB (Part 1: Plasma)Max Planck Institute for Infection BiologyHomo sapiensMS
ST0009761 metabolitesGC6-74 matabolomic of TB (Part 3: Plasma_RPMI)Max Planck Institute for Infection BiologyHomo sapiensMS
ST0011751 metabolitesMulti-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparumMonash UniversityPlasmodium falciparumMS
ST0012011 metabolitesPeroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasitesMonash UniversityPlasmodium falciparum;Homo sapiensMS
ST0012021 metabolitesPeroxide antimalarial treatment timecourse on ring-stage P. falciparum parasitesMonash UniversityPlasmodium falciparum;Homo sapiensMS
ST0012041 metabolitesPeroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasitesMonash UniversityPlasmodium falciparum;Homo sapiensMS
ST0012051 metabolitesPeroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasitesMonash UniversityPlasmodium falciparum;Homo sapiensMS
ST0012321 metabolitesCombining stage - specificity and metabolomic profiling to advance drug discovery for malariaPennsylvania State UniversityPlasmodium FalciparumMS
ST0012741 metabolitesMetabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I)Monash UniversityTrypanosoma brucei bruceiMS
ST0013041 metabolitesMulti-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondiiMonash UniversityToxoplasma gondiiMS
ST0013841 metabolitesPlasmodium falciparum increased time in circulation underlies persistent asymptomatic infection in the dry seasonPenn StateHomo sapiensMS
ST0015471 metabolitesβ-Adrenergic regulation of metabolism in macrophagesMonash UniversityHomo sapiensMS
ST0015481 metabolitesβ-Adrenergic regulation of metabolism in macrophages (part-II)Monash UniversityHomo sapiensMS
ST0015491 metabolitesβ-Adrenergic regulation of metabolism in macrophages (part-III)Monash UniversityHomo sapiensMS
ST0016601 metabolitesPlasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitorsPennsylvania State UniversityPlasmodium falciparumMS
ST0017881 metabolitesβ-Adrenergic regulation of metabolism in macrophages (part-IV)Monash UniversityHomo sapiensMS
ST0018351 metabolitesUse of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage PhenotypesIdaho Veterans Research and Education FoundationHomo sapiensMS
ST0018731 metabolitesMetabolomics analysis of multiple samples on AB 5600-Part 1Dalian Institute Of Chemical PhysicsHomo sapiensMS
ST0018741 metabolitesMetabolomics analysis of multiple samples on Agilent 6546-Part 1Dalian Institute Of Chemical PhysicsHomo sapiensMS
ST0018751 metabolitesMetabolomics analysis of multiple samples on AB 5600-Part 2Dalian Institute Of Chemical PhysicsMus musculusMS
ST0018761 metabolitesMetabolomics analysis of multiple samples on Agilent 6546-Part 2Dalian Institute Of Chemical PhysicsMus musculusMS
ST0018971 metabolitesA local source of insulin in the eye governed by phagocytosis and starvationUniversity of VirginiaMus musculusMS
ST0019831 metabolitesMetabolomic Fingerprinting of Human High Grade Serous Ovarian Carcinoma Cell LinesUniversity of Oklahoma Health Sciences CenterHomo sapiensMS
ST0019851 metabolitesProfiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183Pennsylvania State UniversityPlasmodium falciparumMS
ST0020101 metabolitesChemoresistant Ovarian Cancer Global MetabolomicsThe University of South AustraliaHomo sapiensMS
ST0020111 metabolitesThe anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases.Pennsylvania State UniversityPlasmodium falciparumMS
ST0020241 metabolitesPlasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruptionPennsylvania State UniversityPlasmodium falciparumMS
ST0020781 metabolitesMultiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target.Pennsylvania State UniversityPlasmodium falciparumMS
ST0020942 metabolitesCommensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1)Mayo ClinicHomo sapiensMS
ST0021041 metabolitesChemoresistant Cancer Cell Lines are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling PerturbationsFuture Industries InstituteHomo sapiensMS
ST0021061 metabolitesGenetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1)Monash UniversityPlasmodium falciparumMS
ST0021071 metabolitesGenetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2)Monash UniversityPlasmodium falciparumMS
ST0021081 metabolitesGenetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3)Monash UniversityPlasmodium falciparumMS
ST0022341 metabolitesA metabolic map of the DNA damage response identifies PRDX1 in nuclear ROS scavenging and aspartate synthesisCRGHomo sapiensMS
ST0023221 metabolitesMetabolomics study comparing SCAP KO and WT B cellsIndiana University School of MedicineMus musculusMS
ST0024931 metabolitesComposition of raw plant-based food items Pilot StudyMassachusetts Institute of TechnologyMalus domestica/Solanum lycopersicum/Lactuca sativa/Fragaria x ananassa/Allium sativum/Ocimum basilicumMS
ST0025551 metabolitesEthnicity-Specific Differences in Ovarian Cancer Metabolic SignaturesUniversity of Oklahoma Health Sciences CenterHomo sapiensMS
ST0027921 metabolitesChemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malariaMonash UniversityPlasmodium falciparumMS
ST0029261 metabolitesMulti-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expressionMonash UniversityPlasmodium falciparumMS
ST0030661 metabolitesHeritability of RBC metabolites: baseline correlation of metabolites and markers of RBC health and stabilityUniversity of IowaHomo sapiensMS
ST0031601 metabolitesNew class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasitesMonash UniversityPlasmodium falciparumMS

Return to search page
  logo